The expression ratio of Map7/B2M is prognostic for survival in patients with stage II colon cancer

Craig Blum, Amanda Graham, Matt Yousefzadeh, Jessica Shrout, Katie Benjamin, Murli Krishna, Raza Hoda, Rana Hoda, David J. Cole, Elizabeth Garrett-Mayer, Carolyn Reed, Michael Wallace, Michael Mitas

Research output: Contribution to journalArticlepeer-review

22 Scopus citations

Fingerprint

Dive into the research topics of 'The expression ratio of Map7/B2M is prognostic for survival in patients with stage II colon cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences